Kelley Wood: What is the cost of inactivity in oncology care?
Kelley Wood, Research Director at ReVital Cancer Rehabilitation, posted on LinkedIn about recent paper by Ronaldo Corrêa Ferreira da Silva et al., titled “Current and future costs of cancer attributable to insufficient leisure-time physical activity in Brazil” published on Plos One.
Authors: Ronaldo Corrêa Ferreira da Silva, Thainá Alves Malhão, Leandro F. M. Rezende, Rafael da Silva Barbosa, Arthur Orlando Correa Schilithz, Luciana Grucci Maya Moreira, Paula Aballo Nunes Machado, Fabio Fortunato Brasil de Carvalho, Maria Eduarda Leão Diogenes
“What is the cost of inactivity in oncology care?
Strong research evidence shows low physical activity increases risk of poor outcomes including all-cause and cancer-related mortality – but how does it affect the healthcare bottom line?
A new study estimates costs attributable to inactivity in Brazil may be as high as $64 million USD by 2030, representing approximately 3% of federal direct healthcare costs.
Authors estimated improved physical activity levels by 2030 could save the healthcare system 3 to 8.9 million USD in 2040.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023